Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00196534 · ClinicalTrials.gov registry record · Phase 3
A Study to Compare Human Thrombin Against Bovine Thrombin in Its Ability to Stop Bleeding After Surgery
A Phase 3 study, sponsored by Ethicon.
- Completed
- Registry status
- Phase 3
- Development phase
- 304
- Enrollment target
NCT00196534 is a Phase 3 study that has completed, run by Ethicon. The registered enrollment target is 304 participants.
The verdict
NCT00196534, a Phase 3 study, has completed, sponsored by Ethicon.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 304 participants
- Enrollment target
Study Summary
The purpose of this study is to see if Human Thrombin is as effective as Bovine Thrombin in stopping surgical bleeding within 10 minutes of application.
Interventions
- DRUG Human Thrombin
- DRUG Bovine Thrombin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 304 participants |
| Start Date | 2004-11 |
| Est. Completion | 2006-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00196534
The ClinicalTrials.gov registry entry for NCT00196534 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 304 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ethicon, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Human Thrombin is the first listed.
NCT00196534 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00196534 about?
NCT00196534 is a clinical study titled "A Study to Compare Human Thrombin Against Bovine Thrombin in Its Ability to Stop Bleeding After Surgery". The purpose of this study is to see if Human Thrombin is as effective as Bovine Thrombin in stopping surgical bleeding within 10 minutes of application.
What is the current status of trial NCT00196534?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 304 participants. The study started on 2004-11. Estimated completion is 2006-07.
What interventions are being tested in trial NCT00196534?
The interventions under investigation include: Human Thrombin (DRUG), Bovine Thrombin (DRUG).
Who is sponsoring clinical trial NCT00196534?
This trial is sponsored by Ethicon, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.